The Impact of Obesity on the Presentation of Primary Hyperparathyroidism
H. D. Tran(Johns Hopkins University), Naim M. Maalouf(Southwestern Medical Center), Fiemu E. Nwariaku(The University of Texas Southwestern Medical Center), Stacey Woodruff(Monash University), Jennifer Rabaglia(The University of Texas Southwestern Medical Center), Beverley Adams‐Huet(Southwestern Medical Center), Jacob S. Grange, Shelby Holt(Southwestern Medical Center)
Cited by 34
Related Papers
Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels
|Circulation|2001|732
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|514
Association of urinary pH with body weight in nephrolithiasis
|Kidney International|2004|404
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
|Journal of the American Society of Nephrology|2009|386
POTASSIUM-MAGNESIUM CITRATE IS AN EFFECTIVE PROPHYLAXIS AGAINST RECURRENT CALCIUM OXALATE NEPHROLITHIASIS
|The Journal of Urology|1997|371